Search results for "Diabetes"


 
Results 121 - 130 of about 960 for "Diabetes".
Sort by: Relevance | Newest | Oldest

Earn trust, counter misinformation

Physicians are on the front lines of addressing medical misinformation, increasingly figuring out what to address and how.
https://immattersacp.org/archives/2023/06/earn-trust-counter-misinformation.htm
1 Jun 2023

Statins' benefits outweigh their association with diabetes incidence

Statins' benefits outweigh the risk of diabetes for patients taking the drugs for secondary prevention and those at high risk of major adverse coronary events, a study found.
https://immattersacp.org/weekly/archives/2012/08/14/4.htm
14 Aug 2012

Thrombolysis may benefit acute ischemic stroke patients with diabetes and prior stroke

Thrombolysis appeared to benefit patients with acute ischemic stroke who had concomitant diabetes or a history of stroke, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/22/6.htm
22 Nov 2011

Silent epidemic: Alcohol and preventable death, despair

Alcohol use disorder is often linked to poverty, unemployment, social isolation, and other social determinants of health, and medicine must address these underlying factors to genuinely reduce the risks associated with alcohol.
https://immattersacp.org/archives/2023/07/silent-epidemic-alcohol-and-preventable-death-despair.htm
1 Jul 2023

More compounded products recalled, diabetes drug approved

This regulatory update covers a recall of a compounding pharmacy's products due to mold and approval of a sodium-glucose co-transporter for diabetes.
https://immattersacp.org/archives/2013/06/fda.htm
1 Jun 2013

Be on alert for blood cancer precursors

Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
https://immattersacp.org/archives/2023/07/be-on-alert-for-blood-cancer-precursors.htm
1 Jul 2023

Choice of third oral diabetes drug can depend on each patient's needs

There is no clear choice for a third oral agent for controlling A1c levels above 7% following metformin and a sulfonylurea, researchers concluded from a meta-analysis of type 2 diabetics, so the best choice depends on the patient's need.
https://immattersacp.org/weekly/archives/2011/05/17/1.htm
17 May 2011

Updated warnings on fluoroquinolones, new diabetes drug

This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016

Treatment pathways compared for diabetic peripheral neuropathy

Amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin were similarly effective for controlling pain, a recent study found.
https://immattersacp.org/weekly/archives/2022/08/30/2.htm
30 Aug 2022

GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes

An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021

Result Page: Prev   8   9   10   11   12   13   14   15   16   17   Next